Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tabrecta
Pharma
AZ, HutchMed get China nod for Orpathys for rare type of NSCLC
With Orpathys, AZ and HutchMed are the first in China to receive approval for a treatment against a rare form of NSCLC.
Kevin Dunleavy
Jun 23, 2021 11:17am
New Novartis campaign message? Cancer continues during COVID-19
Feb 11, 2021 9:30am
Merck KGaA matches Novartis with FDA green light for Tepmetko
Feb 4, 2021 12:09pm
Novartis beats out Merck KGaA with lung cancer drug Tabrecta
May 6, 2020 3:07pm
